首页> 中文期刊> 《中国医院用药评价与分析》 >对重症社区获得性肺炎患者抗感染治疗的药学监护

对重症社区获得性肺炎患者抗感染治疗的药学监护

         

摘要

OBJECTIVE:To probe into the pharmaceutical care for one case with severe community acquired pneumonia in anti-infection treatment by clinical pharmacists , so as to provide reference for the rational application of drugs . METHODS:The clinical pharmacists participated into the adjustment of anti-infection treatment for one case with severe community acquired pneumonia and the evaluation of efficacy , and provided pharmaceutical care for the patient .RESULTS:The clinical pharmacists provided effective pharmaceutical care for the patient during the anti-infection treatment , timely identified the problems and proposed relevant solutions to improve the therapeutic effects .CONCLUSIONS: The clinical pharmacists participate into the treatment process of anti-infection treatment for patients , and provide necessary pharmaceutical care can improve the drug efficacy and safety and promote rational drug application .%目的:探讨临床药师参与重症社区获得性肺炎患者抗感染治疗的药学实践,为合理用药提供参考。方法:临床药师参与1例重症社区获得性肺炎患者抗感染治疗方案的调整及疗效评估,为重症社区获得性肺炎患者提供药学监护。结果:临床药师为该患者的临床抗感染治疗提供了有效的药学监护,及时发现了药物治疗中存在的问题,并提出了解决方案,提高了治疗效果。结论:临床药师积极参与患者的药物治疗过程,为患者提供必要的药学监护,可提高药物治疗的有效性和安全性,促进合理用药。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号